Early Detection of Insulin Resistance: A Reflection on Dr. Kraft’s Work
Originally published in Townsend Letter. Summary and reflections provided by Meridian Valley Lab.
Why Glucose Isn’t the Full Picture
Most practitioners rely on fasting glucose and A1C values to detect insulin resistance. But these metrics can miss signs of metabolic imbalance for years. Dr. Joseph Kraft, a pathologist who analyzed over 14,000 glucose-insulin tolerance tests (GTIR), found that many patients classified as “normal” using glucose metrics were actually insulin resistant.
Understanding Kraft Patterns
Dr. Kraft’s GTIR test included insulin values alongside glucose readings. This approach uncovered five patterns of insulin response. Four of these indicate insulin resistance, even when glucose appears normal. These findings challenge the assumption that glucose levels alone reflect metabolic health.
GTIR vs. Traditional OGTT
Show Section
Unlike a standard Oral Glucose Tolerance Test (OGTT), the GTIR measures insulin and glucose over time. This dual insight helps clinicians detect prediabetes earlier and intervene with lifestyle or therapeutic changes before full-blown diabetes develops.
Clinical Case Example
Show Section
In one case, a woman in her late 30s showed normal glucose and A1C but had insulin levels consistent with Kraft Pattern II. Early detection allowed for targeted intervention, helping prevent long-term metabolic damage.
A Simpler, Fingerstick-Based GTIR Test [Currently Only Available as a Blood Draw]
Show Section
Meridian Valley Lab offers a modern version of Kraft’s test: a fingerstick GTIR panel. This dried blood spot collection method makes testing easier for patients while preserving the robust diagnostic insight of Kraft’s original method.
Who Should Be Screened?
Show Section
Anyone with a family history of diabetes, metabolic syndrome, obesity, or PCOS may benefit from early insulin testing. Even individuals with “normal” glucose values may show silent insulin resistance when measured with GTIR.
Public Health Implications
Insulin resistance precedes type 2 diabetes by 10–20 years. Catching it early can help reduce the burden of chronic disease and health care costs. Widespread screening using GTIR could be transformative for preventive care.
Final Thoughts on Prevention & Cost Savings
Dr. Kraft’s legacy reminds us that prevention starts before disease takes hold. At Meridian Valley Lab, we remain committed to offering innovative, accessible testing that aligns with this vision. We believe that patient outcomes improve when clinicians have the right tools to detect and intervene early.
References
Click to view references
- World Health Organization: Diabetes Programme. Retrieved from www.who.int
- American Diabetes Association: Diagnosing Diabetes and Learning About Pre-Diabetes. Retrieved from www.diabetes.org
- Kraft JR. Detection of diabetes mellitus in situ (occult diabetes). Lab Med. 1975. 6(2):10–22.
- Kraft JR. Diabetes Epidemic and You. 2011. Bloomington, IN: Trafford.
- CDC National Diabetes Statistics Report, 2014. Retrieved from www.cdc.gov
To request the full reference list for this blog, please contact our team.
